Introduction
Our vision for HUPO2017 Congress on “Integrated Proteomics for Healthcare Systems” is to create a meeting that will bring together world leaders with a new generation of scientists to promote HUPO’s capabilities for advancing our knowledge of the Human Proteome and the impact this will have on our understanding of health, disease and ageing. The Congress will celebrate past achievements and present new disruptive advances in proteomics. This will be achieved by a balanced scientific programme that takes into account previous milestone developments in proteomics, the current state of the art as well as newly arising areas and opportunities.
The programme will include key outreach events as well as sessions devoted to each of the twelve (12) current HUPO Initiatives and to the three (3) pillars of the HPP.
In recognition of the increasing role of proteomics in medicine development and point of care testing, and the consequential impact on the biopharmaceutical industry, we will have a special focus on the application of proteomics in clinical trials, therapeutic protein production and disease diagnosis, including opportunities for brainstorming and networking to provide solutions in global healthcare.
Call for paper
Important date
Submission Topics
The 16th World Congress of the Human Proteome (HUPO 2017) covers topics such as:
-
Cancer & Translational Proteomics
-
Antibodies and Protein Arrays
-
Chemical Proteomics & Profiling Drug Targets
-
Chemical Probes & Chemical Biology for Proteomics
-
Diabetes & Cardiovascular Diseases: Energy balance in disease phenotypes (HPP)
-
Cys Modifications & Redoxomics
-
Food & Nutrition and Immuno-Peptidome: Focus on food allergies (HPP)
-
Extracellular & Membrane Proteomics
-
Imaging & Single Cell Proteomics
-
Glycoproteomics - Technical Limitations & Prospects
-
Innovative MS Techniques for Global & Targeted Proteomics
-
Immunity, Inflammation & Infectious Diseases
-
Interactomics & Protein Network
-
Integrative Glyco(proteo)mics for Glycosylation Disorders
-
Liver & Toxicoproteomics: Metabolism, drug transformation & toxicity (HPP)
-
Kidney, Urine & Plasma: Opportunities for early diagnosis and risk assessment (HPP)
-
MS Informatics & Mining Multivariate Proteomic Datasets
-
Metabolomics & Metabolic Disorders
-
New Technological Advancements
-
Neurological Disorders & Brain Proteomics
-
Plant & Microbial Proteomics
-
Pharmacoproteomics & Drug Discovery
-
Proteogenomics & The Missing Proteins/peptides
-
Protein Standards & Model Organisms: Expanding our horizons (HPP)
-
PTM Crosstalks I - Phosphoproteomics, Kinome & OGlcNAc
-
Proteome Dynamics: Turnover & Degradomics
-
Spatial Proteomics
-
PTM Crosstalks II - Lysine & other modificomics
All Comments
Important Date
-
Conference Date
Sep 17
2017
toSep 20
2017
-
Apr 05 2017
Abstract Submission Deadline
-
Sep 20 2017
Registration deadline
Contact Information
Submit Comment